These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

20 related articles for article (PubMed ID: 4708159)

  • 1. 125IUDR labelling efficiency and cytotoxicity for murine tumours in vivo and in vitro.
    Hagmar B; Ryd W
    Eur J Nucl Med; 1982; 7(3):108-14. PubMed ID: 7067712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of murine leukemia virus structural antigens on the surface of chemically induced murine sarcomas.
    Grant JP; Bigner DD; Fischinger PJ; Bolognesi DP
    Proc Natl Acad Sci U S A; 1974 Dec; 71(12):5037-41. PubMed ID: 4373739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitation of cytotoxic antitumor antibody in vitro: a microassay with 125I-iododeoxyuridine as a tumor cell label.
    Fritze D; Kern DH; Pilch YH
    J Natl Cancer Inst; 1974 Nov; 53(5):1403-7. PubMed ID: 4431057
    [No Abstract]   [Full Text] [Related]  

  • 4. Host immunity to a growing transplanted methylcholanthrene-induced guinea pig sarcoma.
    Cohen AM; Millar RC; Ketcham AS
    Cancer Res; 1972 Nov; 32(11):2421-6. PubMed ID: 5082590
    [No Abstract]   [Full Text] [Related]  

  • 5. Study of a microassay for the quantitation of cytotoxic antitumor antibody, using 125I-iododeoxyuridine as a target cell label; detection of a static effect on cell DNA synthesis.
    Le Mevel BP; Wells SA
    Biomedicine; 1976 Dec; 24(6):434-42. PubMed ID: 1022316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of lymphocytes and serum of C3Hf-Bu mice during the growth of methylcholanthrene-induced tumor and its regression following local irradiation.
    Jurin M; Suit HD
    Cancer Res; 1974 Apr; 34(4):672-8. PubMed ID: 4814987
    [No Abstract]   [Full Text] [Related]  

  • 7. A microassay for humoral cytotoxicity demonstrating sublethal effects of antibody.
    Cleveland PH; McKhann CF; Johnson K; Nelson S
    Int J Cancer; 1974 Sep; 14(3):417-26. PubMed ID: 4459274
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanisms of immunological enhancement.
    Cruse JM; Lewis GK; Whitten HD; Watson ES; Fields JF; Adams ST; Harvey GF; Paslay JW; Porter M
    Prog Exp Tumor Res; 1974; 19():110-56. PubMed ID: 4140539
    [No Abstract]   [Full Text] [Related]  

  • 9. A microassay for the guantitation of cytotoxic antitumor antibody: use of 125 I-iododeoxyuridine as a tumor cell label.
    LeMevel BP; Wells SA
    J Natl Cancer Inst; 1973 Mar; 50(3):803-6. PubMed ID: 4708159
    [No Abstract]   [Full Text] [Related]  

  • 10. Fundamental concepts in tumor immunology: a brief review.
    Mastrangelo MJ; Laucius JF; Outzen HC
    Semin Oncol; 1974 Dec; 1(4):291-5. PubMed ID: 4620436
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.